Results 291 to 300 of about 367,278 (369)

Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Although small intestinal adenocarcinoma (SIA) shares certain similarities with colorectal cancer, its etiology and predisposing conditions presumably are distinct. Due to the rarity of SIA, however, detailed information on predisposing factors is lacking.
Jasmijn D. G. Linssen   +8 more
wiley   +1 more source

Saw-Tooth Cardiomyopathy

open access: yesJACC: Case Reports, 2020
Pablo Garcia-Pavia, MD, PhD   +1 more
doaj  

Antitumor efficacy of intermittent low‐dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Novel immunomodulatory insights derived from experimental models and clinical samples reveal the cancer‐preventive potential of intermittent low‐dose erlotinib plus sulindac (ERL + SUL). This study shows that ERL + SUL treatment upregulates MHC class I and II expression and remodels the immune cell niche, with significant tumor suppression ...
Chakrapani Tripathi   +17 more
wiley   +1 more source

Inflammation-Associated Carcinogenesis in Inflammatory Bowel Disease: Clinical Features and Molecular Mechanisms. [PDF]

open access: yesCells
Hisamatsu T   +7 more
europepmc   +1 more source

Screening outcomes at second FIT screening in individuals with a first time negative FIT‐result or low‐risk adenomas: Results from a nationwide FIT screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Fecal immunochemical test (FIT) screening is increasingly common as a population‐based screening tool for colorectal cancer (CRC). If the follow‐up colonoscopy after a positive FIT detects only low‐risk adenomas, those participants are recommended to continue biennial screenings, the same as people with negative FIT results.
Pernille Thordal Larsen   +4 more
wiley   +1 more source

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease. [PDF]

open access: yesJ Crohns Colitis
Leite-Gomes E   +17 more
europepmc   +1 more source

p16INK4a and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2—A historical cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Immunohistochemical biomarkers are increasingly used for the grading of cervical intraepithelial neoplasia (CIN); however, their clinical utility in the prediction of CIN2 regression is largely unexplored. Here, the authors analyzed the risk of CIN2 regression in relation to p16INK4a and HPVE4 immunohistochemistry in a large cohort of women
Rikke Damgaard   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy